28
Apr
Remplir™ RWE study delivers 90% success rate
Orthocell has announced compelling new data from its ongoing Remplir™ Real World Evidence (RWE) study, demonstrating strong and consistent clinical outcomes across a broad range of peripheral nerve repair procedures. The latest results show an overall treatment success rate of 89.7%, based on performance data from 66 participants undergoing 78 nerve repair procedures. This expanding dataset reinforces Remplir’s clinical utility and supports the […]
30
Apr
Remplir™ nerve repair study published in peer-reviewed clinical journal
Orthocell has announced that results from the Remplir™ nerve regeneration clinical trial have been published in a high profile clinical journal.